Stock market today: S&P 500 drops for fifth day as focus shifts to Powell’s speech
Core Scientific, Inc. (NASDAQ:CORZ), currently valued at $4.32 billion, finds itself at a pivotal juncture as it navigates a strategic shift towards High-Performance Computing (HPC) while grappling with the complexities of a pending acquisition by CoreWeave (NASDAQ:CRWV). According to InvestingPro analysis, the stock appears overvalued at its current price of $14.66, despite showing strong momentum with a 40% return over the past year. This comprehensive analysis delves into the company’s recent performance, strategic initiatives, and the potential implications of the proposed merger, offering insights for investors considering CORZ stock.
Company Overview and Recent Performance
Core Scientific has been transforming its business model, pivoting from its roots in Bitcoin mining to focus on the burgeoning HPC market. This strategic shift comes as the company faces challenges in its traditional mining operations. In recent months, CORZ has experienced a decline in its Bitcoin mining output and energized hash rate, with February 2025 seeing a decrease to 215 Bitcoin mined, down from higher levels in previous months.
Despite these headwinds in its mining segment, the company’s financial projections paint a picture of potential growth, though InvestingPro data shows current challenges with a 39.43% revenue decline in the last twelve months and thin gross profit margins of 8.63%. Analysts project 2025 revenue at $432.6 million, with expectations of significant improvements in earnings per share (EPS) and Adjusted Funds From Operations (AFFO) in the coming years. AFFO is anticipated to grow from $0.29 in 2025 to $1.17 by 2027, indicating a positive trajectory for the company’s cash-generating capabilities. For deeper insights into CORZ’s financial health and growth prospects, investors can access comprehensive analysis through InvestingPro’s detailed research reports.
Strategic Shift to High-Performance Computing
Core Scientific’s pivot to HPC represents a strategic response to market dynamics and an effort to capitalize on the growing demand for advanced computing resources. The company’s partnership with CoreWeave, a key player in the HPC space, has been central to this transition. CORZ has committed to supplying 590 MW of space and power to CoreWeave, a deal that analysts suggest could support a valuation significantly higher than the company’s current market price.
The HPC focus has already begun to bear fruit, with CORZ reporting a growing pipeline of potential large-scale deals ranging from 50-100 MW with various enterprise clients. Management has expressed confidence in the company’s ability to reduce its dependence on CoreWeave, aiming to decrease CoreWeave’s share of billable capacity to less than 50% by the end of 2028.
Pending Acquisition by CoreWeave
The proposed all-stock acquisition of Core Scientific by CoreWeave has become a focal point for investors and analysts alike. The deal, which values CORZ at an implied ~$12.35 per share based on recent CRWV stock prices, appears conservative compared to analyst targets ranging from $15 to $23 per share. The deal has faced scrutiny and opposition from some shareholders, most notably Two Seas Capital LP, which owns 6.3% of CORZ. InvestingPro analysis reveals the company maintains healthy liquidity with a current ratio of 1.79, potentially strengthening its negotiating position.
Critics argue that the current terms undervalue Core Scientific’s assets and potential, particularly given the company’s commitments in the HPC space. Some analysts suggest that the Net Present Value (NPV) of CoreWeave’s contractual commitment alone could support a valuation above $20.00 per share for CORZ, with additional assets potentially pushing that figure closer to $50 per share.
The acquisition’s success remains uncertain, as it depends heavily on CRWV’s fluctuating stock price and faces potential regulatory and shareholder hurdles. A termination fee of $270 million adds another layer of complexity to the deal’s dynamics.
Future Outlook and Growth Potential
Looking ahead, Core Scientific’s growth prospects appear tied to its ability to execute its HPC strategy and navigate the potential acquisition by CoreWeave. The company is on track to bring additional megawatts of capacity online throughout 2025, with 48 MW expected in Q2, 90 MW in Q3, and 95 MW in Q4. By the end of 2025, CORZ anticipates a run-rate colocation revenue of approximately $360 million.
Analysts project significant improvements in the company’s financial performance, with EPS expected to turn positive after a challenging 2024. The potential for CORZ as a standalone operator remains strong, given the constrained data center capacity and high demand from hyperscalers in the HPC market.
Bear Case
How might shareholder opposition affect the CoreWeave acquisition?
Shareholder opposition, particularly from significant stakeholders like Two Seas Capital LP, poses a substantial risk to the completion of the CoreWeave acquisition. If a sufficient number of shareholders vote against the deal, it could force a renegotiation of terms or potentially derail the merger altogether. This uncertainty may lead to increased volatility in CORZ’s stock price and could impact the company’s ability to execute its strategic plans effectively.
What risks does CORZ face if the acquisition falls through?
If the acquisition fails to materialize, Core Scientific would face several challenges. First, the company would be liable for a $270 million termination fee, which could strain its financial resources. Additionally, CORZ would need to rapidly adjust its strategy as a standalone entity, potentially requiring new partnerships or capital infusions to fund its HPC expansion plans. The market might also react negatively to the failed deal, potentially leading to a decrease in the stock price and making it more difficult for the company to raise capital in the future.
Bull Case
How could CORZ benefit from the growing demand for HPC capacity?
The increasing demand for HPC capacity presents a significant opportunity for Core Scientific. As more enterprises and research institutions require advanced computing resources for AI, machine learning, and data analytics, CORZ is well-positioned to capitalize on this trend. The company’s existing infrastructure and partnerships, particularly its relationship with CoreWeave, provide a strong foundation for growth in this sector. Successful execution of its HPC strategy could lead to substantial revenue increases and improved profitability, potentially driving the stock price higher.
What potential upside exists for CORZ as a standalone company?
As a standalone entity, Core Scientific has the potential to unlock significant value for shareholders. The company’s HPC pipeline and existing contracts, including the 590 MW commitment from CoreWeave, support a valuation that some analysts believe could exceed $40 per share. By diversifying its customer base beyond CoreWeave and continuing to expand its HPC capacity, CORZ could position itself as a leading independent provider of high-performance computing infrastructure. This scenario could result in higher margins, improved cash flow, and potentially a higher market valuation compared to the current acquisition offer.
SWOT Analysis
Strengths:
- Strong focus on high-growth HPC market
- Established partnership with CoreWeave
- Significant infrastructure and capacity expansion plans
- Improving financial projections and AFFO growth
Weaknesses:
- Current dependence on CoreWeave for a large portion of revenue
- Declining performance in Bitcoin mining operations
- Uncertainty surrounding the pending acquisition
Opportunities:
- Growing demand for HPC and AI infrastructure
- Potential for large-scale deals with enterprise clients
- Expansion into new geographic markets and data center locations
Threats:
- Shareholder opposition to the CoreWeave acquisition
- Market volatility affecting CRWV stock price and deal valuation
- Intense competition in the HPC and data center markets
- Regulatory challenges in the cryptocurrency and technology sectors
Analysts Targets
- Jefferies: Buy rating with a price target of $22.00 (August 18th, 2025)
- JMP Securities: Market Perform rating, no price target provided (August 12th, 2025)
- Cantor Fitzgerald: Overweight rating with a price target of $18.00 (June 27th, 2025)
- JMP Securities: Market Outperform rating with a price target of $15.00 (May 22nd, 2025)
Core Scientific’s future remains a subject of intense debate among analysts and investors. As the company continues its transition towards HPC and navigates the complexities of the proposed CoreWeave acquisition, market participants will be closely watching for developments that could significantly impact CORZ stock. This analysis is based on information available up to August 18, 2025.
Want to make more informed decisions about CORZ? InvestingPro offers exclusive insights, including 10 key investment tips, comprehensive financial health scores, and detailed valuation metrics. Access our Pro Research Report for a deep dive into what really matters about CORZ, transforming complex Wall Street data into clear, actionable intelligence for smarter investing decisions.
InvestingPro: Smarter Decisions, Better Returns
Gain an edge in your investment decisions with InvestingPro’s in-depth analysis and exclusive insights on CORZ. Our Pro platform offers fair value estimates, performance predictions, and risk assessments, along with additional tips and expert analysis. Explore CORZ’s full potential at InvestingPro.
Should you invest in CORZ right now? Consider this first:
Investing.com’s ProPicks, an AI-driven service trusted by over 130,000 paying members globally, provides easy-to-follow model portfolios designed for wealth accumulation. Curious if CORZ is one of these AI-selected gems? Check out our ProPicks platform to find out and take your investment strategy to the next level.
To evaluate CORZ further, use InvestingPro’s Fair Value tool for a comprehensive valuation based on various factors. You can also see if CORZ appears on our undervalued or overvalued stock lists.
These tools provide a clearer picture of investment opportunities, enabling more informed decisions about where to allocate your funds.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.